Andrew K Balo Dexcom Inc (DXCM) insider trading activity

DXCM Quotes by TradingView

Andrew K Balo is EVP Regulatory Strategy Clinic of DEXCOM INC. Currently has a direct ownership of 50,908 shares of DXCM, which is worth approximately $4.39 Million. The most recent transaction as insider was on Mar 10, 2023, when has been sold 11,670 shares (Common Stock) at a price of $111.4 per share, resulting in proceeds of $1,300,038. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.9K
0% 3M change
0% 12M change
Total Value Held $4.39 Million

Andrew K Balo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2023
SELL
Sale (or disposition) back to the issuer
$1,300,038 $111.4 p/Share
11,670 Reduced 18.65%
50,908 Common Stock
Mar 09 2022
SELL
Sale (or disposition) back to the issuer
$1,392,786 $406.06 p/Share
3,430 Reduced 18.01%
15,615 Common Stock
Mar 08 2022
BUY
Grant, award, or other acquisition
-
4,984 Added 20.74%
19,045 Common Stock
Sep 09 2021
SELL
Other acquisition or disposition
-
2,498 Reduced 15.09%
14,056 Common Stock
Jun 03 2021
SELL
Other acquisition or disposition
-
18,774 Reduced 53.17%
16,533 Common Stock
Mar 10 2021
SELL
Open market or private sale
$2,020,013 $362.92 p/Share
5,566 Reduced 13.62%
35,307 Common Stock
Mar 08 2021
BUY
Grant, award, or other acquisition
-
5,301 Added 11.48%
40,873 Common Stock
AKB

Andrew K Balo

EVP Regulatory Strategy Clinic
San Diego, CA

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DXCM